CME Dinner Symposium

Sunday, November 6, 2022
7:30 p.m. – 9:00 p.m.
Marriott Marquis
Room: Great Lakes EF
2121 South Prairie Avenue,
Chicago IL, 60616

Located in South Downtown Chicago, connected to the McCormick Place and the main AHA Sessions! 

AGENDA

Opening Remarks and Introductions
Cardiovascular Protection in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes (T2D)
  • CKD as a cardiovascular risk factor
  • The importance of identifying CKD to improve CVD risk assessment: new implications and perspectives
  • Novel Nonsteroidal MRAs in Patients with CKD and T2DM
  • Rationale and mechanisms of action
  • Cardiorenal risk reduction: evidence from clinical trials
  • The Role of Nonsteroidal MRAs in Cardiovascular Care
  • How nonsteroidal MRAs fit in with other cardioprotective therapies
  • Guideline updates & patient selection
  • Patient Case, Panel Discussions and Future Directions
    Q & A and Conclusions

    Key Reasons to Attend

    • Learn more about the importance of chronic kidney disease and type 2 diabetes as major drivers of cardiovascular morbidity and mortality
    • Be up-to-date about the data with novel nonsteroidal MRAs in cardiorenal risk reduction, and how this new approach fits in with existing treatment options 
    • Hear from top-experts on how to apply this evidence to reduce the risk of cardiovascular and renal adverse events in patients with chronic kidney disease and type 2 diabetes
    • Earn up to 1.5 CME/CE Credits
    •  

    Chaired by:

    RESERVE YOUR SEAT

    Pre-Register below to be added to our VIP attendance list and be given priority to join this event.
    Registration to this event is complimentary, however you must be a registered attendee of the 2022 Scientific Sessions. 

    RESERVE YOUR SEAT

       

    This activity is jointly provided by Global Education Group and Cardiometabolic Health Congress.

    This satellite symposium is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

    This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.